Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
CytoPherx
company
About
CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $11.70M
- Industries
- Health Care,Life Science,Medical Device
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$11.70M
CytoPherx has raised a total of
$11.70M
in funding over 2 rounds. Their latest funding was raised on
Jun 17, 2010 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 17, 2010 | Series B | $11.70M | 1 |
Diamond Capital Management
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
CytoPherx is funded by 1 investors.
Diamond Capital Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Diamond Capital Management
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
